Butylmalonate is a transition state analogue for aminocylase I  by Röhm, Klaus-Heinrich
Volume 250, number 2, 191-194 FEB 07242 July 1989 
Butylmalonate is a transition state analogue for aminocylase I 
Klaus-Heinrich Riihm 
Institut fiir Physiologische Chemie der Philipps-Universitiit. D-3550 Marburg(Lahn), FRG 
Received I7 March 1989; revised version received 21 April 1989 
Butylmalonate (butyl propanedioic acid) is a slow-binding inhibitor of porcine renal aminoacylase I (EC 3.5.1.14), caus- 
ing transients of activity with half-times of more than 10 min. At 25°C and pH 7.0, the dissociation rate of the complex 
is approximately 6x 1O-4 s-i, while the rate constant of complex formation is in the order of 20 M-‘.s-i. In good agree- 
ment with these data, steady-state kinetics yield an estimated inhibition constant around 100 PM. Molecular mechanics 
calculations howed that conformation and charge distribution of butylmalonate are strikingly similar to those of the 
putative transition state of aminoacylase catalysis. 
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1. INTRODUCTION 
Aminoacylase I from porcine kidney (EC 
3.5.1.14) is inhibited by a variety of N-substituted 
amino acids, including p-toluenesulfonyl-, t- 
butyloxycarbonyl-, or trichloroacetyl derivatives 
[ 1,2]. The inhibition constants for all of these com- 
pounds are in the millimolar range; in general, they 
are similar to the K,,, values of structurally related 
substrates. Free amino acids are poor inhibitors, 
except at high pH, when their amino groups are 
uncharged [3]. Highest aminoacylase activities or, 
in the case of substrate analogues, highest degrees 
of inhibition are observed with substituted 
straight-chain aliphatic amino acids [4]. So N- 
acetyl norleucine (N-acetyl cr-aminohexanoic acid) 
is among the best aminoacylase substrates. 
When screening a series of potential 
aminoacylase inhibitors, we noticed that 
butylmalonic acid (butylpropanedioic acid) in- 
hibits the enzyme in a time-dependent fashion. The 
results of a more detailed study on the mechanism 
of butylmalonate inhibition are described in the 
present paper. 
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2. EXPERIMENTAL 
2.1. Materials 
Aminoacylase I was purified from hog kidney as described 
elsewhere [5]. Butylmalonic acid and benzylmalonic acid are 
commercially available. 
2.2. Methods 
Aminoacylase activities were measured by flow injection 
analysis according to a published procedure [5]. This method is 
more reliable than the conventional spectrophotometric assay, 
especially when the reaction has to be followed for some time. 
All assays were performed at 25°C in 50 mM Mops/NaOH, pH 
7.0, with acetyl-L-Met as the substrate. Kinetic parameters were 
estimated by non-linear regression analysis with our KINFIT 
program [6]. 
Molecular mechanics calculations were performed using the 
MMX force field (Serena Software, Bloomington, IN, USA), 
which is an enhanced version of Allinger’s MMP2 [7]. In con- 
trast to former programs, MMX also handles transition states. 
3. RESULTS 
Under the conditions of our experiments, 
butylmalonate inhibition of aminoacylase- 
catalyzed acetyl-L-Met hydrolysis was a surprising- 
ly slow process. When the reaction was started by 
adding enzyme to substrate and inhibitor (fig.1, 
curve 2) the rate of product release gradually 
decreased for more than half an hour before 
reaching a new steady-state level. On the other 
hand, when the enzyme was preincubated with in- 
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Fig. 1. Time course of inhibition by butylmalonate at 25°C. The 
samples contained 50 mM Mops/NaOH, pH 7.0, 8.3 mM 
acetyl-L-Met and 0.4 mM butylmalonate (curves 2 and 3 only). 
The reaction was started with enzyme (curve 2) or with substrate 
after a 30 min preincubation of enzyme with butylmalonate 
(curve 3). Curve 1 shows the uninhibited reaction. Product 
concentrations were measured by flow injection analysis with 
fluorimetric detection [5]. Solid lines (curves 2 and 3) are fits of 
eqn I (see text) with the following parameters: curve 2, - vi = 
0.51 f 0.02 units.min-‘, vr = 0.18 + 0.04 units.min-‘, k = 
0.071 f 0.018 min-‘; curve 3, -vi = 0.072 k 0.008, vr = 
0.218 + 0.027, k = 0.056 + 0.02; curve 1 is a linear fit with v., = 
0.71 + 0.01. 
hibitor for 20-30 min before adding substrate 
(curve 3), activity increased for about 15 min to at- 
tain the same final value. In the absence of in- 
The solid lines in fig.1 are fits of eqn I (cf. [8]) 
hibitor the time course of product release was 
[P]t = Vf’t+(Vi-Vf)‘(l -e+‘)/k (1) 
strictly linear (curve 1). 
where [PI, is the product concentration at time t, 
vi is the initial rate after starting the reaction, vr is 
the final velocity, and k is the first-order rate con- 
stant of the transient. For curves 2 and 3 first- 
order rate constants around 1 x low3 s-l were ob- 
tained which corresponds to a half-time of about 
12 min. 
The dependence of Li and vr on substrate concen- 
tration is shown in fig.2. Note that the saturation 
curve for the uninhibited reaction is distinctly 
sigmoidal (see also fig.3, upper curve). Statistical 
tests [6] applied to the respective parameter 
estimates confirmed that the deviation from hyper- 
bolic behaviour is highly significant at the 95% 
level. So far, sigmoidal kinetics were only found 
with substrates bearing extended unbranched alkyl 
side chains. With acetyl-L-Ala or chloroacetyl-l- 
[s] CmM) 
Fig.2. Dependence of butylmalonate inhibition on substrate 
concentration. Experimental conditions were as in fig. 1 except 
that 0.09 mM butylmalonate was employed. Velocities of the 
uninhibited reaction (vO, 0) as well as initial (vi, A) and 
steady-state rates (vr, v) in the presence of butylmalonate are 
plotted vs the concentration of acetyl-L-Met. Solid lines are fits 
of the Hill equation with the following parameters: v0 - V = 
7.0 + 0.6 units, [S]O.S = 1.20 + 0.21 mM, Hill coefficient n = 
1.55 + 0.25; Vi - I’= 7.0 + 0.5, [S]O.S = 2.1 f 0.3, n = 1.6 f 
0.3; vr- V = 6.6 k 0.8, [S]o.s = 7.3 i 1.5, n = 1.2 f 0.1. 
Ala, both routinely used in our laboratory, non- 
hyperbolic kinetics are not observed. 
The vr values in fig.2 do not allow a clear-cut 
distinction between hyperbolic and sigmoidal 
kinetics. However, from the results of curve fit- 
ting, it is obvious that the substrate concentration 
at half-maximal velocity [S]O.~ for vr was much 
[S] (mM) 
Fig.3. Inhibition of aminoacylase by benzylmalonate. Assay 
conditions were as in fig. 1. Velocities in the absence of inhibitor 
(0) and in the presence of 9.3 mM benzylmalonate (A) are 
plotted vs substrate concentration. Bars indicate standard 
deviations. Solid lines are fits of the Hill equation with V = 
20.3 f 0.8, [S]O.S = 1.53 f 0.13 mM, n = 1.74 + 0.15 (0) or of 
the Michaelis-Menten equation with V = 20.8 f 2.2, [S]O.S = 
3.7 + 0.7 mM (A). 
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higher than the [S]O.S values for v. or vi, while the since model II predicts that Ki = kodkon. On the 
maximal velocities were the same within ex- other hand, the competitive scheme is not strictly 
perimental error. Applying the competitive model applicable to cooperative systems, which renders 
of inhibition to fig.2 and using [S]O.S for com- the above comparison somewhat questionable. In 
parison, we estimate an inhibition constant Ki of any case, the data show that butylmalonate is not 
about 1OOpM. This value is markedly lower than an exceptionally tight-binding inhibitor because its 
any published value for aminoacylase inhibitors. rate of association is slow, too. 
In contrast to butylmalonate, benzylmalonate 
did not exhibit slow-binding effects. Inhibition by 
this analogue was competitive (that is, V was un- 
changed) with an inhibition constant of 6.2 mM 
(fig.3). The Michaelis constant for acetyl-L-Phe is 
6.0 mM under the same conditions [5]. 
4. DISCUSSION 
Morrison [8] has defined ‘slow-binding’ in- 
hibitors as compounds that exert their effects on 
the target enzyme in a reversible manner but at 
rates low enough to be measured by ordinary 
kinetic techniques. Many of these inhibitors are 
also ‘tight-binding’, i.e., effective at exceptionally 
low concentrations. 
Most cases of slow-binding inhibition are due to 
a very slow rate of dissociation of the enzyme- 
inhibitor complex. A recent review [9] cites cases 
where reversible competitive inhibitors are released 
from the enzyme with half-times of years. The 
simplest model to describe slow-binding interac- 
tions is the classical scheme for competitive in- 
hibition 
In recent years evidence has accumulated in- 
dicating that a large fraction of slow-binding in- 
hibitors mimic intermediates in enzyme catalysis 
[9]. For instance, there is good evidence that pep- 
tidase inhibitors like bestatin [l l] or leupeptin [lo] 
are analogues of the tetrahedral transition state 
formed by nucleophilic attack of a water molecule 
or a hydroxyl ion at the carbonyl group of amide 
substrates. In order to examine whether 
butylmalonate may act by a similar mechanism, we 
employed molecular mechanics calculations to 
study the presumed transition state for 
SNZhydrolysis of N-acetyl norleucine. A confor- 
mation obtained by global energy minimization of 
such a structure is shown in fig.4. It is a ‘late’ tran- 
sition state with a fractional bond order of 0.8. 
Clearly, the oxygen atoms at the transition state 
carbon (marked by #) and the cY-carboxylate ox- 
ygens form a structure resembling dianionic 
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When both the time course of inhibition after 
starting with enzyme and the time course of partial 
reactivation after preincubation with inhibitor can 
be followed, the rate constants of association and 
dissociation, k,,, and koff may be estimated 
[B,lO,ll]. Applying the method of Baici and 
Gyger-Marazzi [lo] to the data of fig.1, we find 
k.,ff = 6 + 2 x lop4 s-l and an association constant 
k,, between 10 and 40 M-r. s-l. These results are 
in reasonable agreement with the estimated steady- 
state inhibition constant of about 1OOpM (fig.2), 
Fig.4. Conformation of the transition state of acetyl norleucine 
hydrolysis (see text). 
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Fig.5. A comparison of the transition state? of acetyl norleucine 
hydrolysis (a) with butylmalonate (b), see text. 
malonate. This similarity becomes quite obvious 
by inspection of fig.5, where the same transition 
state (a) and butylmalonate (b) are viewed along 
the direction of the respective butyl side chains. It 
can be seen that the inter-oxygen distances in both 
conformations are almost identical. The same 
holds for the distribution of negative charges, since 
one of the transition state oxygens bears a frac- 
tional charge close to unity. 
Our observation that benzylmalonate acts as a 
normal competitive inhibitor indicates that the 
transition states for the aminoacylase-catalyzed 
hydrolysis of aromatic substrates may be different. 
As compared to aliphatic compounds, the turnover 
numbers of N-acyl derivatives of aromatic amino 
acids are lower by l-2 orders of magnitude, 
although the stabilities of the scissile amide bonds 
are comparable [4,5]. We assume that the bulky 
side chains of such substrates impede catalysis. 
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